| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |